Achieving Patient Buy-In and Long Term Compliance with Antihypertensive Treatment
作者:
Frances B. Garfield,
J. Jaime Caro,
期刊:
Disease Management & Health Outcomes
(ADIS Available online 2000)
卷期:
Volume 7,
issue 1
页码: 13-20
ISSN:1173-8790
年代: 2000
出版商: ADIS
关键词: Antihypertensives, therapeutic use;Hypertension, treatment;Patient compliance;Pharmacoeconomics
数据来源: ADIS
摘要:
Noncompliance is a major problem in antihypertensive treatment. Up to 50% of patients are noncompliant after 1 year and 85% after 5 years. Current approaches for predicting compliance are based on patient demographics, medication characteristics and clinical factors, health beliefs and the quality of patient-provider communication. All of these factors together predict compliance only less than half the time, indicating that over half of the patients in disease management programmes may not buy-in to their treatment.A new approach views compliance as behaviour change that takes place over time. Patients move through 5 stages in their ‘readiness to comply’. Our study of over 700 patients with hypertension using brief self-report measures to assess their ‘readiness to comply’ found a highly significant relationship between ‘readiness to comply’ and reported compliance. Clinicians can increase patient buy-in and long term compliance by assessing their patients ‘stage-of-change’ using validated measures and then matching their interventions to each patient's ‘readiness to comply’.
点击下载:
PDF
(83KB)
返 回